AADBYXX

ETF / Mutual Fund
NASDAQ
Citigroup Global Markets Holdings Inc. Capped Dual Directional Barrier Note AADBYXX
Health Care
Price Chart
Overview

About AADBYXX

A clinical-stage biopharmaceutical company developing transcription factor decoy technologies for pain and inflammatory diseases.

AUM
$6.0
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for AADBYXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AADBYXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AADBYXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM$6.0
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AADBYXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025